Research into conolidine has brought about discovery of an opioid receptor in the body known as ACKR3/CXCR7. ACKR3 appears to be essentially the most wanted target for conolidine, which also disregards one other four classical opioid receptors(three). Sign up for a member to learn when there is clinical evidence https://lorenza047njd5.elbloglibre.com/profile